Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial - Wei, Jing; Zhang, Pengfei; Hu, Qiancheng; Cheng, Xiaolong; Shen, Chaoyong; Chen, Zhixin; Zhuang, Wen; Yin, Yuan; Zhang, Bo; Gou, Hongfeng; Yang, Kun; Bi, Feng; et al. (Frontiers in Immunology, 2025)